Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
GLP-1 medications are a distinct pharmaceutical intervention
All products are intended for research, laboratory, and analytical use only
At some point, the work needs to happen somewhere the count sheet cant reach
Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (with or Without Sulfonylureas) in Insulin-Naive Patients with Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Multinational, Phase 3a Trial
The authors systematically searched PubMed and Embase from inception to 1 May 2025 for cohort studies comparing the effect of combination therapy with SGLT2 inhibitor or GLP-1 RA monotherapy on (cardiovascular) mortality and cardiovascular or kidney endpoints in individuals with type 2 diabetes
Keeton R, Tincho MB, Ngomti A, Baguma R, Benede N, Suzuki A, et al
US$ 26.68
US$ 24.30
US$ 22.49
US$ 27.68
US$ 21.21
US$ 20.99
US$ 26.35
US$ 28.56
US$ 23.45
.webp)
US$ 20.63
US$ 24.50
